LVGO - Teladoc Is A Strong Buy: A Radical Healthcare Change Will Come

• If you still had shares of Livongo, they were probably exchanged for Teladoc shares somewhere last week.
• We look at what's wrong with healthcare as it is now, how it can be fixed, and how Teladoc and Livongo could help to cure the system.
• What Livongo brings to Teladoc and what Teladoc becomes after the merger: the only one-stop-shop for digital healthcare.
• We are on the edge of a revolution in healthcare with converging trends like cheap genome sequencing, CRISPR editing, AI, and personalized medicine and Teladoc is well-placed to profit from the trends.
• If you look at the digital healthcare market alone, it represents a TAM of $510B.

For further details see: